The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access?
This webinar will explain how pricing has evolved for the rare disease drug market and…
Certara2020 年 2 月 19 日
How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs
This webinar will explain how Certara expanded its PBPK Simcyp Simulator to incorporate an extensive…
Certara2020 年 1 月 24 日
How to Perform IVIVC for Delayed Release Drug Formulations
This webinar showed how to use a time correction factor to establish a meaningful IVIVC…
Certara2019 年 8 月 20 日
Innovative Solutions for Fast-Tracking Drugs for Rare Diseases
This webinar discussed which pharmaceutical payer strategies work and which don't in our rapidly changing…
Certara2019 年 8 月 10 日
Advanced Analytics Using RWD Mitigates Risks in AD Drug Development & Reimbursement
This webinar explained how advanced analytics using real-world data can mitigate challenges in Alzheimer’s disease…
Certara2019 年 5 月 13 日
How to Perform IVIVC for Extremely Long Acting Drugs
Watch this webinar to learn how to use in vitro and in vivo models to…
Certara2019 年 2 月 22 日
How to Use a Reference-scaled Average Bioequivalence Approach for Narrow Therapeutic Index Drugs
Watch this webinar to learn how RSABE for NTIDs can be performed in Phoenix WinNonlin…
Certara2018 年 9 月 25 日
Using IVIVC to Optimize Your Drug Formulation After a Failed BA/BE Study
This webinar introduced how IVIVC can be used to get your drug program back on…
Certara2018 年 7 月 18 日
Using Virtual Twin® Technology to Predict Drug Exposure in Individual Patients
In this webinar, Dr. Tom Polasek, a clinical pharmacologist at Certara Strategic Consulting, explained how…
Certara2018 年 3 月 8 日
